Tissue-resident memory T cells (TRM) provide frontline protection against pathogens and emerging malignancies. Tumor-infiltrating lymphocytes (TIL) with TRM features are associated with improved clinical outcomes. However, the cellular interactions that program TRM differentiation and function are not well understood. Using murine genetic models and targeted spatial transcriptomics, we found that the CD8+ T cell-derived chemokine XCL1 is critical for TRM formation and conventional DC1 (cDC1) supported the positioning of intestinal CD8+ T cells during acute viral infection. In tumors, enforced Xcl1 expression by antigen-specific CD8+ T cells promoted intratumoral cDC1 accumulation and T cell persistence, leading to improved overall survival. Notably, analysis of human TIL and TRM revealed conserved expression of XCL1 and XCL2. Thus, we have shown that the XCL1-XCR1 axis plays a non-cell autonomous role in guiding intestinal CD8+ TRM spatial differentiation and tumor control.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1084/jem.20240776 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity.
J Exp Med
March 2025
School of Biological Sciences, University of California, San Diego, La Jolla, CA, USA.
Tissue-resident memory T cells (TRM) provide frontline protection against pathogens and emerging malignancies. Tumor-infiltrating lymphocytes (TIL) with TRM features are associated with improved clinical outcomes. However, the cellular interactions that program TRM differentiation and function are not well understood.
View Article and Find Full Text PDFInflammatory response in traumatic brain and spinal cord injury: The role of XCL1-XCR1 axis and T cells.
CNS Neurosci Ther
June 2024
Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Article Synopsis
- Traumatic brain injury (TBI) and spinal cord injury (SCI) are major health issues leading to significant physical, social, and economic challenges worldwide, with current treatment options being ineffective.* -
- The review highlights the critical role of the XCL1-XCR1 axis and T-cell response in the inflammatory processes following TBI and SCI, indicating a shift from focusing solely on glial cells to including lymphocytes like CD8 T cells.* -
- The study identifies potential therapeutic targets within the inflammatory pathways involving various cytokines and immune cells, emphasizing the need for further research into these mechanisms for better treatment options.*
Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.
Signal Transduct Target Ther
May 2024
Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
Article Synopsis
- Conventional type 1 dendritic cells are vital for antitumor immunity, and inhibiting BCL9/BCL9L can enhance immune responses and slow tumor growth.
- Targeting BCL9/BCL9L leads to better antigen presentation in tumors by activating cDC1 and promoting their infiltration, as evidenced by the use of a novel inhibitor and knockout models.
- Single-cell transcriptomics analysis reveals that cDC1 lacking Bcl9/Bcl9l are more effective in activation and antigen presentation, suggesting that manipulating BCL9/BCL9L could improve cancer immunotherapy outcomes.
XCL1, a serum biomarker in neurological diseases; HTLV-1-associated myelopathy and multiple sclerosis.
Microb Pathog
January 2023
Rheumatic Diseases Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:
The XCL1-XCR1 axis has a potential role in the recruitment of immune cells to the site of inflammation. The present study aimed to examine the relation of XCL1 serum levels with Multiple sclerosis (MS) and HTLV-1-associated myelopathy (HAM), as chronic inflammatory diseases of the central nervous system (CNS). DNA was extracted to evaluate HTLV-1 proviral load (PVL) using real-time PCR.
View Article and Find Full Text PDFSystems analysis reveals complex biological processes during virus infection fate decisions.
Genome Res
June 2019
Infection Biology Laboratory, Department of Experimental and Health Sciences (DCEXS), Universitat Pompeu Fabra, Barcelona, Catalonia 08003, Spain.
The processes and mechanisms of virus infection fate decisions that are the result of a dynamic virus-immune system interaction with either an efficient effector response and virus elimination or an alleviated immune response and chronic infection are poorly understood. Here, we characterized the host response to acute and chronic lymphocytic choriomeningitis virus (LCMV) infections by gene coexpression network analysis of time-resolved splenic transcriptomes. First, we found an early attenuation of inflammatory monocyte/macrophage prior to the onset of T cell exhaustion, and second, a critical role of the XCL1-XCR1 communication axis during the functional adaptation of the T cell response to the chronic infection state.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!